Back to Search
HARALD HALL, M.D.
M.D.
Rheumatology Physician
NPI: 1982661021Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
PMID 17139649·Arthritis Rheum·2006
5-case
RIP2 contributes to Nod signaling but is not essential for T cell proliferation, T helper differentiation or TLR responses.
PMID 18085666·Eur J Immunol·2008
7-preclinical
Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis.
PMID 18220797·Curr Pharm Des·2007
6-review
Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
PMID 15501236·Microvasc Res·2004
7-preclinical
Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
PMID 15609076·Angiogenesis·2004
8-other
N-terminal alpha-dystroglycan binds to different extracellular matrix molecules expressed in regenerating peripheral nerves in a protein-mediated manner and promotes neurite extension of PC12 cells.
PMID 14697669·Mol Cell Neurosci·2003
7-preclinical
Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro.
PMID 11678634·Microvasc Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 50 MAUDE ST
PROVIDENCE, RI 02908 - Phone
- (401) 456-2157
Quick Facts
- NPI
- 1982661021
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile